We engineer medicine based not on a single target, but the biological network as a whole.

Arpeggio is developing the world's fastest platform for transcriptomic sequencing to learn how chemistry maps to network biology.

99.5% of adults over fifty will have a chronic disease by 2040. We're working on developing a pipeline of potential drugs to tackle drug resistance in cancer, chronic kidney disease, and neurodegeneration.

Arpeggio is a team of computer scientists, biologists, and entrepreneurs using functional genomics to find new therapeutic targets for hard to treat diseases like cancer. We believe that building tomorrow’s medicines will require an integrated perspective that combines ideas and methods from disparate scientific fields. Our team and the work we do directly reflects this multidisciplinary approach.

We're always searching for highly driven scientists, executives, and engineers to join our team pushing the boundaries of medicine. Please reach out to us!